Zenouzi, R; Schmiedel, S; Lohse, AW
Pyogenic Liver Abscess: a Retrospective Patient StudyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 50. H. 6. 2012 S. 578-584
Schmalfeldt, B; Seck, K; Gonschior, AK et al.
Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis aloneGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 72. H. 4. 2012 S. -
Larrey, D; Lohse, AW; de Ledinghen, V et al.
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinJOURNAL OF HEPATOLOGY. Bd. 57. H. 1. 2012 S. 39-46
Xu, Zhuo; Juhlin, Christopher; Gudmundsson, Olafur et al.
Reconstruction of subsurface structure from ambient seismic noise: an example from Ketzin, GermanyGEOPHYSICAL JOURNAL INTERNATIONAL. Bd. 189. H. 2. 2012 S. 1085-1102
Heydenreich, B; Bellinghausen, I; Lorenz, S et al.
Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cellsIMMUNOLOGY. Bd. 136. H. 2. 2012 S. 208-217
Freisinger, Wolfgang; Lale, Nena; Lampert, Angelika et al.
RENAL AFFERENT NEURONS EXHIBIT AN ALTERED FIRING PATTERN IN AN IN VITRO MODEL OF KIDNEY INFLAMMATIONNEPHROLOGY DIALYSIS TRANSPLANTATION. Bd. 27. 2012 S. 446-447
Lutz, Jens
Renal Cell Carcinoma - NSAR increase Risk of DiseaseAKTUELLE UROLOGIE. Bd. 43. H. 5. 2012 S. 296-298
Dewit, Olivier; Hebuterne, Xavier; Dupas, Jean-Louis et al.
Results of a Phase II, Randomized, Double Blind, Controlled Trial of the Efficacy of Active Therapeutic Immunization With TNF-Kinoid in Patients With Moderate to Severe Crohn's Disease With Secondary Resistance to TNF alpha AntagonistGASTROENTEROLOGY. Bd. 142. H. 5. 2012 S. S567-S568
Maerker-Hermann, E.; Gross, W. L.
Rheumatic Diseases in different Stages of LifeINTERNIST. Bd. 53. H. 9. 2012 S. 1017-1018
Schuetz, N.; Maerker-Hermann, E.
Rheumatoid arthritis and multiple myeloma as comorbidity. Is tocilizumab a therapy option?ZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 71. H. 1. 2012 S. 78-+